These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35970837)

  • 1. Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo.
    Ni H; Hatit MZC; Zhao K; Loughrey D; Lokugamage MP; Peck HE; Cid AD; Muralidharan A; Kim Y; Santangelo PJ; Dahlman JE
    Nat Commun; 2022 Aug; 13(1):4766. PubMed ID: 35970837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo.
    Huayamares SG; Lokugamage MP; Rab R; Da Silva Sanchez AJ; Kim H; Radmand A; Loughrey D; Lian L; Hou Y; Achyut BR; Ehrhardt A; Hong JS; Sago CD; Paunovska K; Echeverri ES; Vanover D; Santangelo PJ; Sorscher EJ; Dahlman JE
    J Control Release; 2023 May; 357():394-403. PubMed ID: 37028451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery.
    Da Silva Sanchez AJ; Zhao K; Huayamares SG; Hatit MZC; Lokugamage MP; Loughrey D; Dobrowolski C; Wang S; Kim H; Paunovska K; Kuzminich Y; Dahlman JE
    J Control Release; 2023 Jan; 353():270-277. PubMed ID: 36423872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transcriptional Response to Lung-Targeting Lipid Nanoparticles
    Radmand A; Lokugamage MP; Kim H; Dobrowolski C; Zenhausern R; Loughrey D; Huayamares SG; Hatit MZC; Ni H; Del Cid A; Da Silva Sanchez AJ; Paunovska K; Schrader Echeverri E; Shajii A; Peck H; Santangelo PJ; Dahlman JE
    Nano Lett; 2023 Feb; 23(3):993-1002. PubMed ID: 36701517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput
    Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
    ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands.
    Lokugamage MP; Sago CD; Gan Z; Krupczak BR; Dahlman JE
    Adv Mater; 2019 Oct; 31(41):e1902251. PubMed ID: 31465135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery.
    Tilstra G; Couture-Senécal J; Lau YMA; Manning AM; Wong DSM; Janaeska WW; Wuraola TA; Pang J; Khan OF
    J Am Chem Soc; 2023 Feb; 145(4):2294-2304. PubMed ID: 36652629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands.
    Gan Z; Lokugamage MP; Hatit MZC; Loughrey D; Paunovska K; Sato M; Cristian A; Dahlman JE
    Bioeng Transl Med; 2020 Sep; 5(3):e10161. PubMed ID: 33758781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
    Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
    J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
    Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
    Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver.
    Kim M; Jeong M; Hur S; Cho Y; Park J; Jung H; Seo Y; Woo HA; Nam KT; Lee K; Lee H
    Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33637537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing.
    Sago CD; Lokugamage MP; Paunovska K; Vanover DA; Monaco CM; Shah NN; Gamboa Castro M; Anderson SE; Rudoltz TG; Lando GN; Munnilal Tiwari P; Kirschman JL; Willett N; Jang YC; Santangelo PJ; Bryksin AV; Dahlman JE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9944-E9952. PubMed ID: 30275336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild Innate Immune Activation Overrides Efficient Nanoparticle-Mediated RNA Delivery.
    Lokugamage MP; Gan Z; Zurla C; Levin J; Islam FZ; Kalathoor S; Sato M; Sago CD; Santangelo PJ; Dahlman JE
    Adv Mater; 2020 Jan; 32(1):e1904905. PubMed ID: 31743531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
    Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
    Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
    Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System.
    Pattipeiluhu R; Arias-Alpizar G; Basha G; Chan KYT; Bussmann J; Sharp TH; Moradi MA; Sommerdijk N; Harris EN; Cullis PR; Kros A; Witzigmann D; Campbell F
    Adv Mater; 2022 Apr; 34(16):e2201095. PubMed ID: 35218106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.
    Geisler HC; Ghalsasi AA; Safford HC; Swingle KL; Thatte AS; Mukalel AJ; Gong N; Hamilton AG; Han EL; Nachod BE; Padilla MS; Mitchell MJ
    J Control Release; 2024 Jul; 371():455-469. PubMed ID: 38789090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
    Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
    Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
    Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
    Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.